Workplace Drug & Alcohol Testing Testimonials: Randox Testing Services

Home - Archives for Randox Communications

Workplace Drug & Alcohol Testing Testimonials: Randox Testing Services

24 November 2020

Workplace Drug & Alcohol Testing Testimonials : How Randox Testing Services can help

With the widespread availability of drugs and alcohol, there is an increased risk of substance abuse in the workplace leading to huge ramifications for a business and its employees. Jeopardising the safety of not only the user, but also their co-workers and in some cases the general public, it affects the whole business environment and puts those present at serious risk of harm.

RTS work with a wide range of companies who seek to reduce the impact of substance use and its potential impact in the workplace.

Below are several testimonials from companies we have helped to implement a testing programme – whether that be a drug and alcohol testing programme using different sample types and testing protocols, or an education initiative educating employees on the dangers of substance misuse when in the workplace.

Read the testimonials below.

 

McLaughlin & Harvey

McLaughlin & Harvey have engaged Randox Testing Services for our Random, With-Cause & Post Incident Drugs & Alcohol employee and contractor screening throughout UK & Ireland since 2017.

We have found RTS to be professional, reliable and highly competent in support of our drugs & alcohol testing programme. RTS have provided excellent on-site testing, customer service and reliable laboratory results when required.

RTS have consistently performed within our service level agreement and I would have no hesitation in recommending them for drug & alcohol testing services.

 

MacFarlane Packaging

In 2018, I was tasked with trialling new providers for our Drug and Alcohol testing for our Group. It was apparent quite early on that compared to some of the other leading providers we also tested, that Randox Testing Services outshone the rest.

The service has always been personal to our needs and consistent, which assists us in managing our responsibilities with confidence.

Along with the Drug and Alcohol Testing we have recently acquired a sample of COVID 19 testing kits to trial and again the service has been prompt and efficient.

I would have no hesitation in recommending Randox Testing Services to others.

 

Titan Airways

Randox Testing Services has consistently provided an excellent reliable, service, which has enabled us to have the necessary flexibility within our unique operation, to continue to operate and provide assurances to our customers during these challenging times.

Our account manager is exceptionally obliging and has been available to answer any questions or concerns to ensure a rapid response, not only in the delivery of products, but also providing a link with technicians who process our results. This gives us the reassurances and confidence to meet commercial demands.

The general quality of service is excellent and Randox Testing Services always go over and above to ensure they deliver the finest high-quality service to us.

 

H&MV Engineering

We have used Randox Testing Services (RTS) for the past 2 years. We have found their service to be very professional and all queries are dealt with swiftly and with integrity.

We look forward to continuing or relationship with RTS over the coming years.

 

Graham Construction

Graham Construction are proud to be partnered with Randox Testing Services as their main drug and alcohol service provider.

Over the years they have given a consistent, prompt, efficient and professional service that delivered what was promised, when promised, to the proper agreed standards, which assists us in managing our relevant responsibilities with ease and confidence.

We would have no hesitation in recommending them to others.

 

Mabey Hire

Randox Testing Services have provided Mabey Hire with an exceptional service for workplace drug and alcohol testing for many years. You can speak to any member of the team from customer services, collection staff and your account manager who are always willing to help and are highly experienced. It’s great to know that you have the support you need when it’s needed.

We have found them to be reliable and deliver a prompt turnaround of clear and accurate reports. They have provided a service tailored to us and our drug and alcohol policy.

 

CAE Parc Aviation

We use Randox Testing Services for pre-employment and random drug and alcohol testing for select clients.

We would happily recommend their services.

 

Yorwaste

Yorwaste first engaged with Randox Testing Services in 2015 to develop a post-incident, with-cause testing policy. RTS were instrumental in helping us developing a policy and introduce the process to the business. In addition, they offered management training to help develop the business’ understanding of what to look for and do in relation to drugs and alcohol in the workplace.

We are currently looking at introducing pre-employment screening and, with RTS, exploring the benefits of this approach for our business.

We as a business would strongly recommend RTS in helping develop and deliver a robust approach to drugs and alcohol in the workplace.

 

Contact Randox Testing Services

At Randox Testing Services it is our aim to help employers provide a safer workplace by reducing the dangers of drugs & alcohol. We work with companies to inform & educate on how illicit substances can have untold dangers to staff and impact the productivity of a business.

If you would like to find out more about our services, or any of the testimonials above, get in touch with us to arrange a consultation with one of our drug & alcohol testing experts, using any of the below methods.

Website: www.randoxtestingservices.com

Email: testingservices@randox.com

Phone: +44 (0) 28 9445 1011

 

Want to know more?

Contact us or visit our website to read more.


Response to Channel 4 Dispatches Monday 16th November

Randox Logo

   

The claims made about Randox in the Channel 4/Dispatches documentary ‘Lockdown Chaos: How the Government lost Control’ are underhand, deceptive, dishonest and defamatory and the producers have been notified of the true position.

 

Underhand, deceptive and dishonest behaviour hampers the fight against the pandemic

“This Channel 4 Dispatches “investigation” and use of an undercover reporter grossly misrepresents the facts on the ground and – more importantly – the hard work of all the staff at Randox to expand operations quickly so we can play an important supportive role in the national effort to defeat the pandemic. The journalist was employed for just 10 days in manufacturing and only spent a very limited time in accessioning.  He was not qualified to carry out an “investigation” on quality control measures used in the diagnostics sector. Furthermore, the consultant microbiologist who reviewed the findings of the journalist is a historic opponent of the Pillar 2 testing programme and as such clearly could not provide unbiassed expertise in his review.

“If Dispatches had approached us in an upfront and honest manner with legitimate questions, then we would have worked with them to deliver an accurate and factual programme. This is hatchet job journalism of the worst kind.”

 

Randox wish to state the following:

Randox strongly refute those allegations made regarding Randox’s laboratory operations within the Channel 4 documentary, ‘Lockdown Chaos: How the Government lost Control’, transmitted on 16th November.  Responses to the key allegations are below these more general comments.

Randox wish to state that it is particularly disappointing that Channel 4 and Dispatches appear focussed in portraying a national story of chaos and negativity – without reflecting what has been achieved during the Covid-19 pandemic.

From a standing start, Randox used its extensive experience to develop an innovative assay for Covid-19, built and equipped over 45,000 square feet of specialist molecular laboratories, developed and equipped  a further 50,000 square feet of logistic and technical support space, and mobilised its global supply chains to source equipment and consumables.  Extensive R&D capabilities were also refocussed to support innovation within Covid-19 operations.

Over 750 new staff have been employed.  Randox have invested over £68m of private money in building and resourcing new facilities and have taken testing capacity from 150 molecular assays per day at the end of March 2020 to 80,000 assays per day by early November.  In just over 7 months Randox have reported over 5 million molecular test results to the UK’s Covid-19 National Testing Programme.

There have been significant challenges to face and Randox have committed to the provision of safe, accurate, reliable and timely results at scale, within a culture of continuous process improvement.  As a result Randox often operates efficiently above its committed capacity to the National Testing Programme and meets, or improves upon, the required turnaround times for test results.

Randox, and our staff, do find the use of a covert reporter within our workforce to be disingenuous.  By default that reporter had very limited access, very limited understanding and, it appears, a particularly negative mindset.  Channel 4 could easily have asked for more open access and ensured much more balanced and reputable journalism.

Randox staff are exceptionally dedicated, working to both support and assist those in need of testing, and to optimise processes.  Randox would like to reinforce their thanks and appreciation to all staff who have achieved so much throughout this pandemic.

 

Key Rebuttals:

Allegation: Boxes of samples are unpacked at speed and he (the reporter) was warned there is a recurrent problem of swab samples mistakenly being thrown into the waste with cardboard packaging.

Response: This is a complete misrepresentation; all samples are unpacked for processing and safety checks are carried out on bulk boxes after they have been unpacked.  On the very rare occasion a sample gets accidently caught in the cardboard packaging (estimated 1 in 100,000) it is found and returned to accessioning. There are no recorded cases of samples going to waste.   It is also physically impossible, should there ever be missed samples, for any staff member to ‘get samples all over them’ due to the stringent safety measures of the compactor/baler.  Supervisors do continually stress and can occasionally embellish the importance of due diligence in accessioning, as was evidenced.

Allegation:  Randox accessioning processes run a risk of cross-contamination.

ResponseValid samples are separated from leaked samples, whilst still in leakproof packaging, at the point of accessioning.   Valid samples are wiped down with disinfectant once unpacked; disinfectant is clearly visible on the cloth being used to wipe the tubes, illustrating that tubes are disinfected.  Tubes are then racked in an upright position.  There is no possibility of cross contamination.

 

‘The Expert’

Randox also wish to record their disappointment in the approach undertaken by the ‘expert’ Dr Tom Lewis,  and note the previous stance he has taken on non-NHS laboratories.  Dr Lewis has never operated at the scale or efficiency Randox have achieved, reporting up to 80,000 Covid-19 samples in a single day.  He did not peer review his comments or, noting the inexperience of the undercover reporter (who spent only 4.5 hours in the accessioning area), seek any clarification on processes or procedures from Randox before making his comments.

 

Press enquiries should be emailed to randox@newcenturymedia.co.uk 

Randox in the media

Latest News

FAQs


Randox launches €99 Express COVID-19 Testing Service at Dublin Airport

Randox launches €99 Express COVID-19 Testing Service at Dublin Airport

16 November 2020: Randox launches 99 Express COVID-19 Testing Service at Dublin Airport

A 99 Express COVID-19 Testing Service which launches this week in a new Travel Testing Centre at Dublin Airport, will see the creation of 50 new jobs.

The testing service from Randox, a laboratory partner in the UK’s National COVID-19 Testing Programme, utilises a robust and reliable method of testing known as PCR, which Junior Minister for Transport Hildegarde Naughton described as “the gold standard” for travel testing.

The launch of the Randox Health Travel Centre, which offers rapid next day delivery of results for pre-departure screening as well as on-arrival testing to reduce quarantine timeframes, comes just after Ireland aligned itself with the new EU ‘traffic light’ system to co-ordinate international travel, on Sunday 8th November.

Sophie Boyd, Project Manager for the Randox Express COVID-19 Testing Service, explained;     

 “With the introduction of the new EU traffic lights system, some people will need a COVID-19 test before travelling or equally, will want a negative test result simply for their peace of mind.

“We are delighted to have secured a location at Dublin Airport, that allows us to extend our rapid and reliable COVID-19 Testing Service, already used by a range of well-known companies, airlines and elite sporting organisations, to individual passengers and consumers.”

The Irish Government has agreed that, whilst those arriving from red zones currently have to quarantine for 14 days, this could soon be waived following a negative result from a COVID-19 PCR test taken five days after arrival in Ireland.

Sophie continued;

“Travel requirements during the pandemic continue to evolve, but with the introduction of the EU traffic light system, a common prerequisite to travel or to shorten existing quarantine periods will be a negative PCR COVID-19 test, which is currently the only method of COVID-19 testing recognised and approved by every country worldwide.

“With significant capacity in place to implement high volume PCR testing, we welcome the opportunity to bolster the travel industry’s enormous efforts to restore public confidence in international travel.

“We are committed to providing the most cost-effective and accurate test in the market to assist with the normalisation of travel, and so Randox will be opening a number of regional travel centres across Ireland over the coming weeks.”

Dublin Airport Managing Director Vincent Harrison said the health and safety of passengers and staff had been the airport’s key priority during the pandemic and that continued to be the case;

“We continue to operate a range of globally-recognised COVID-19 safety measures for the health and wellbeing of all airport visitors, and with the official opening of the Randox Health Travel Centre at Dublin Airport we can further support our passengers by offering them access to testing facilities onsite at the airport.”

The Randox €99 Express COVID-19 Testing Service is open to all asymptomatic individuals and operates from the Randox Health Travel Centre beside Terminal 2 at Dublin Airport, as well as at a testing facility in Leopardstown Dublin.

In the coming weeks Randox Health Travel Centres will also open in Galway, Limerick and Cork.

Visit booking.randox.ie to book your appointment.

For further information please email info@randoxhealth.com or phone 0800 2545 130.

     

    Want to know more about Randox?

    Contact us or visit our homepage to view more.

    Our COVID-19 Products and Services

    HOME TEST

    ANTIBODY TEST

    TRAVEL CERTIFICATE

    LABORATORY TOOLS


    The Five Million Tests Milestone: 8th November 2020

    Randox Logo

       

    8TH NOVEMBER: THE 5 MILLION MILESTONE 

    We are pleased to let you know that on Sunday 8th November, Randox surpassed 5 million tests within the UK COVID-19 National Testing Programme.

    That’s an incredible 5 million samples accessioned, processed and tested by our dedicated and talented staff.

    Our staff are our best asset and have risen to the challenge this pandemic has created.

    They have worked hard and flexibly, been creative and innovative, and pulled together as a team to make an impact in the fight against COVID-19.

    We are very proud of their efforts and teamwork.

    Let us once again say thank you to each and every member of Team Randox, for the efforts they have made in 2020.

    What we do at Randox remains vital to the national and global management of COVID-19 and our work is making a real and positive difference.

    We continue to work hard and improve, for the sake of our family, friends and communities.

    For further information please email randoxpr@randox.com

     

     

     

     

     

    Randox in the media

    Latest News

    FAQs


    New Express COVID-19 Testing Service with next day results launched in Dublin

    New Express COVID-19 Testing Service with next day results launched in Dublin

    06 November 2020: New Express COVID-19 Testing Service with next day results launched in Dublin

    A new express COVID-19 testing service has now launched in Ireland, with a rapid next day delivery of results.

    From global diagnostics provider Randox, a laboratory partner in the UK’s National COVID-19 Testing Programme, the service utilises a robust and reliable method of testing known as PCR, the only method recognized and approved for travel testing.

    The PCR testing, which Junior Minister for Transport Transport Hildegarde Naughton described as “the gold standard,” is available in Dublin for pre-travel clearance, or simply for those wanting a COVID-19 test for peace of mind.

    Sophie Boyd, Project Manager for the Randox Express COVID-19 Testing Service, explained;     

     “We appreciate that many people will want a COVID-19 test before travelling home this Christmas, or equally, will want a negative test result to reduce quarantine times and enable them to spend more time with loved ones.

     “PCR testing is currently the only method of COVID-19 testing which is recognised by every country worldwide. Our rapid, accurate and reliable testing service, used already by a range of well-known companies, airlines and elite sporting organisations, will help get plans off to a hassle-free start for travellers and non-travellers alike.”

    The launch of the Randox testing service comes just as Ireland aligns itself with the new EU ‘traffic light’ system to co-ordinate international travel, on Sunday 8th November.

    The Government has agreed that, whilst those arriving from red zones currently have to quarantine for 14 days, this could soon be waived following a negative test result from a COVID-19 test taken five days after arrival in Ireland.

    Sophie continued;

    “Travel requirements during the pandemic continue to evolve, but with the introduction of the EU traffic light system, a common prerequisite will be a negative PCR COVID-19 test prior to travel or to shorten quarantine periods.

    “We have significant capacity in place to implement high volume testing and with our PCR testing service, we look forward to supporting the travel industry’s enormous efforts to restore public confidence in international travel.”

    The Randox Express COVID-19 Testing Service is priced at €99, is open to all asymptomatic individuals and operates from the Clayton Hotel in Dublin.

    Visit booking.randox.ie to book your appointment.

    For further information please email info@randoxhealth.com or phone 0800 2545 130.

      Want to know more about Randox?

      Contact us or visit our homepage to view more.

      Our COVID-19 Products and Services

      HOME TEST

      ANTIBODY TEST

      TRAVEL CERTIFICATE

      LABORATORY TOOLS


      India Must Stop Misusing Antibiotics in Dairy Sector, According to CSE Report

      randox-food-diagnostics

      About RFD        News        Contact Us

      India Must Stop Misusing Antibiotics in Dairy Sector, According to CSE Report

      The Centre for Science and Environment (CSE) has raised concerns over whether the milk we consume is safe. Hosting a virtual meeting in July, the CSE discussed the use of antibiotics with the world’s largest producer of milk, India. Over 188 million tonnes of milk was produced by India over the period of 2018-2019 and lead with 22% of global milk production.

      A recent assessment by the CSE has found indication of antibiotic abuse in milk producing cattle.

      “We have found that antibiotics are extensively misused in the dairy sector; antibiotic residues remain largely untested in milk, an integral part of Indian diets, particularly of children,” said CSE Director General Sunita Narain. “While we continue to struggle against COVID-19, we are staring at another pandemic like situation – that of antibiotic resistance fueled by the way we are producing our food, which has become chemical-intensive.”

      Antibiotics such as penicillin, aminoglycosides and fluroquinolones are being ‘indiscriminately’ used by dairy farmers according to the CSE. These antibiotics are among the most important in human health. The World Health Organisation (WHO) has warned as we face growing concerns over an antibiotic resistance, such antibiotics should be preserved.

      Despite laws stating that antibiotics should only be prescribed and administered by a registered veterinarian, the CSE said that some farmers are illegally attaining and injecting animals themselves without the supervision of veterinarians.

      “Farmers often sell milk while the animal is under treatment, which increases the chances of antibiotic residues in the milk,” explained Amit Khurana, the CSE’s Food Safety and Toxins Programme Director. “While milk sold directly to consumers is not tested, contrary to what one would expect, processed milk sold in packets is also largely unchecked for antibiotic residues.

      “This explains why, despite pooling and processing, packed milk samples from several states had antibiotic residues in the FSSAI’s [Food Safety and Standards Authority of India] milk quality survey of 2018.”

      However, CSE noted the virtual meeting has encouraged positive signs of action in the diary industry in India.

      “The issues highlighted by the CSE assessment have been well recognised by the experts and stakeholders. These experts have also recommended several measures for minimising antibiotic misuse in the Indian dairy sector.”

      In order to minimise the threat of antibiotic resistance, the CSE have recommended “preventative measures” such as;

      • Routine observation of drugs residues in milk
      • Modifying the existing standards for antibiotic residues in milk
      • Limiting misuse of essential antibiotics such as penicillin

      Such measures, Khurana noted, are showing some success. “Information shared by various organisations, agencies and experts suggest that ethno-veterinary medicines, better management of sub-clinical mastitis, and good farm management are contributing towards reducing antibiotic misuse.”

      “India is now talking about antibiotic resistance in the one-health perspective,” noted Narain. “There is a shared concern, and all voices are now together in expressing that concern.” As such he believes further (and necessary) action will be taken.

      “We must ramp up surveillance and testing, put a complete stop to the use of critically important antibiotics and penalise their use,” he added, “and work with farmers and the agriculture-dairy sectors to innovate on solutions.”

      Randox Food Diagnostics

      Randox Food Diagnostics recognise the pressure the dairy industry is under to mass produce high quality products whilst complying with regulations and have developed the solution. A comprehensive range of easy to use, accurate milk analysis methods for the qualitative and quantitative detection of contaminants in milk.

      With 6 Biochip arrays available including the revolutionary InfiniPlex for Milk, Randox Food provide the highest quality testing platforms for the screening of antimicrobials and are the only commercial supplier of a multiplexing anthelmintics array in milk.

      Biochip Array Technology saves time and money whilst enabling users to get a deeper insight into milk quality and ensure a safe supply chain.

      Contact us at info@randoxfooddiagnostics.com, or visit https://www.randoxfood.com/milk-analysis/ to find out more about our milk testing solutions.

       

       

      Want to know more?

      Contact us or visit our Randox Food Diagnostics website.

      Related Products

      Meat & Seafood

      Milk

      Honey

      Wine


      Official comment on extension of COVID-19 testing contract

      Randox Logo

         

      OFFICIAL RANDOX STATEMENT: EXTENSION OF COVID-19 TESTING CONTRACT

      Acknowledging the extension of Randox’s contract to provide COVID-19 testing within Pillar 2 of the UK’s National Testing Programme, Randox Founder and Managing Director Dr Peter FitzGerald said;

      “We take very seriously our responsibility to ensure that vital laboratory testing for Covid-19 continues and expands during the winter months.

      “We have extensively ramped up our capacity and made significant private investment in order to fulfil and exceed our commitment to the National Testing Programme. All at Randox are fully committed to supporting the programme, and we look forward to continuing to play our role, which is crucial to the economic and social wellbeing of the nation.”

      Press enquiries should be emailed to randox@newcenturymedia.co.uk 

       

       

      Randox in the media

      Latest News

      FAQs


      Whole pathogen multiplex controls to support testing for cold, cough and COVID

      News       Coronavirus        Qnostics

       

      27 October 2020

      Whole pathogen multiplex controls to support testing for cold, cough and COVID

      Just in time for flu season, global diagnostics company Randox Laboratories has unveiled a range of whole pathogen multiplex controls that cover multiple viral and bacterial pathogens which cause respiratory disease.

      Inclusive of SARS-CoV-2, Influenza A & B, and Respiratory Syncytial Virus (RSV), the Qnostics Multiplex Respiratory Pathogen Controls (RTX) facilitate diagnosis of the likes of cold and flu, and importantly, the differentiation of these respiratory diseases from COVID-19.

      Using a control line that covers a range of respiratory pathogens in this way will allow laboratories to streamline their testing, consolidate QC, and ultimately save time, money and resource.

      Lynsey Adams, Randox Quality Control Manager, explained;     

      “When the use of time and resources are critical such as in COVID-19 testing, the use of highly characterised controls enables laboratories to meet their daily QC needs and accreditation requirements.

      “Accurate and reliable laboratory testing is an essential aspect of the management of COVID-19 and other respiratory diseases, so we are pleased to be able to offer these new controls which will crucially support the validation, verification and performance monitoring of molecular respiratory assays.”

      The new RTX controls, which are whole pathogen for compatibility with the majority of commercial and in-house assays, are used to monitor the full testing process, from extraction to amplification and detection.

      The Multiplex Respiratory Controls will support public health testing strategies during the incoming flu season and are suited for the test menus of most syndromic assays.

      Lynsey continued;

      “The Randox Qnostics Multiplex Respiratory Pathogen Controls are clinically relevant for full-process validation. Liquid frozen for user convenience and ease of use, the development of the controls using whole pathogen material ensures clinical relevance from extraction to amplification and detection.”

      Randox Qnostics Multiplex Respiratory Pathogen Controls are manufactured to ISO 13485 standards and are in line with ISO 15189:2012 regulatory requirements.

      Key Features and Benefits of the new RTX Controls:

      • Whole pathogen controls – the controls contain the entire genome meaning they are compatible with the majority of commercial and in-house assays.
      • Full process control – whole pathogen controls are the ideal material for full-process validation, monitoring the testing process from extraction to amplification and detection, to ensure ultimate quality assurance in laboratories.
      • Highly characterised – Qnostics controls are quantified by digital PCR to ensure batch to batch reproducibility and are traceable to an internal reference preparation, to ensure metrological traceability of test results obtained by different diagnostic workflows.
      • True Third Party – An independent, unbiased assessment of assay performance is ensured in line with ISO 15189:2012 regulatory requirements.
      • Superior ManufacturingQnostics controls are manufactured under ISO 13485 guidelines to ensure quality and traceability.
      • Liquid for Ease-of-Use – the controls are conveniently supplied in a liquid frozen format meaning there is no additional preparation or handling required.

      For more information visit https://www.randox.com/molecular-infectious-disease-controls/respiratory-infection-testing/

      For further enquiries please email marketing@randox.com

      QNOSTICS

      QCMD

      CORONAVIRUS


      U.S. Drug Overdose Deaths Resurge to Record During the Pandemic

      News       About Us        Randox Toxicology

      22 October 2020: U.S. Drug Overdose Deaths Resurge to Record During the Pandemic

      Drug overdose deaths in the USA rose to a record high in 2019, after falling for the first time for 25 years in 2018. Almost 72,000 people died from drug overdoses in 2019 according to the preliminary data that was released by the Centres for Disease Control and Prevention earlier this year.

      Though there is currently no hard data available, there is speculation that the pandemic is complicating and worsening the surge, as 2020 looks to be even more devastating than 2019. Data collected by The New York Times saw for the first half of 2020 drug overdose deaths have risen by an average of 13 percent across America compared to last year. If this trend continues into the rest of the year, it will be the sharpest rise in annual drug deaths since 2016, when fentanyl made its way into US drug trafficking and street supply.

      Increased funding toward addiction treatment, prevision and recovery services did shows signs of improving overdose deaths. Though the government has made this positive headway in the last few years in how they tackle the drug epidemic in America, this progress could be threatened by the current COVID-19 pandemic.

      Earlier in the month, Brett Giroir, the administration’s assistant secretary for health, said in a statement, “We understand that there is an extraordinary amount of work to do, especially now as we are also dealing with the Covid-19 pandemic that could markedly affect our nation’s mental health and risk of substance use.”

      Several public health experts said conditions created by the pandemic could hurt the nation’s fragile progress in fighting the surge of drug deaths but noted that the overdose rate was on its way back up well before the virus arrived. “Covid just makes it a bit worse,” said Dr. Dan Ciccarone, a professor of medicine at the University of California, San Francisco, who studies the opioid epidemic. “It’s a small wave riding on top of a tsunami that continues to devastate.”

      Although official statistics on 2020 overdose deaths won’t be available for a long time, there is local evidence showing drug related deaths are rising into 2020.

      Increase in Drug related deaths from 2019 through the first portion of 2020

      Though a lot of this data precedes the coronavirus pandemic, researchers believe there are several reasons why the virus could worsen the trend.

      When state lockdowns first began in March, Dr. Anna Lembke, a clinician with Stanford’s Addiction Medicine Dual Diagnosis Clinic, noticed many of her patients showing signs of improving. “Many patients described a kind of peacefulness without the constant hubbub of modern life and the constant triggers they’re exposed to,” she said.

      However, in response to the virus, the US government has done something unheard-of: it relaxed rules and regulations around prescribing methadone and buprenorphine, two commonly prescribed opioid addiction treatments. Patients no longer needed to attend daily in person appointments to receive their methadone prescriptions and could instead be given 4 weeks’ worth at a time. Doctors no longer need to meet in person to prescribe buprenorphine.

      This was initially celebrated as a positive change, however as the pandemic has progressed and people have remained isolated, lockdown has become harmful to people with mental health issues and drug addiction disorders.

      “Social isolation has always been a huge component of drug overdose risk,” said Traci Green, an epidemiologist at Brown University who studies drug abuse and addiction. “So much of what we’ve been trying to do has been completely unravelled.”

      Experts have pointed to other dangers lockdown poses such as;

      • Lack of revival fall back from other users due to an increase in solo drug users
      • Less emotional support as in person visits are scaled back
      • Inconsistent drug strength and quality
      • Supply or income disruption leading to inconsistent drug use habits and accidental overdose

       

      Randox Toxicology

      Using our revolutionary Biochip Array Technology, the Evidence MultiSTAT is a fully automated benchtop analyser that enables onsite, simultaneous testing for up to 21 classical, synthetic or prescription drugs from a single sample in under 20 minutes. This quick and highly reliable technology makes it perfect for use in hospitals and medical centres, as pressure increases with the rising number of drug overdose deaths in the US.

       

      To find out more about our Biochip Array Technology and our Evidence Series range of analysers, visit www.randoxtoxicology.com or email info@randoxtoxicology.com

      Randox Toxicology Products and Services

      BIOCHIP

      EVIDENCE

      ELISA

      MATRICES

      Want to know more about Randox?

      Contact us or visit our homepage to view more.


      RTS Blog: Use of Reporting Services in Medico-Legal Cases

      19 October 2020: Use of Reporting Services in Medico-Legal Cases

      At Randox Testing Services we provide several reporting options that are available for use should they be required in medico-legal cases, including expert witness reports and medical reviews to add clarity and expert examination to results.

      Why is Drug and Alcohol Testing in Medico-legal Cases Important?

      Drug and alcohol testing is important to ensure child protection from the detrimental effects of parental substance misuse and to ensure they have a quality of life they deserve. In addition, it is also important to enable parents the opportunity to get the help and support they need and begin rehabilitation treatment.

      Doing the right thing by the child is the main priority, and where possible parent and child relationships are sought to be maintained. Drug and alcohol testing assists in these efforts and in such cases abstinence monitoring testing may be required to assess a parent’s recovery e.g. if a visitation case is being reassessed.

      Expert Witness Services

      An Expert Witness Report is an interpretation of the results of a drug or alcohol test. It provides a detailed explanation of whether substances tested for were detected as well as information regarding chain of custody compliance and testing procedures.

      As trusted industry experts Randox Testing Services staff are trained to act as Expert Witnesses in legal cases involving drug and alcohol testing. Our experienced team of Reporting Scientists have undergone extensive Expert Witness training to provide professional witness statements or fully written reports for use as evidence in a court of law or industrial tribunals.

      Where required a Senior Toxicologist from Randox Testing Services can attend legal proceedings in person to provide expert witness testimony.

      Medical Review Officer

      Our medical review service offers independent and expert examination of positive results under medical confidentiality.

      A positive result from a drug and alcohol analysis is a cause for concern. However, there are some cases when there is a legitimate medical reason for the result. Our medical review service allows for the independent and confidential review of the result to determine the cause of a positive result, for example, if an employee is taking prescription medication.

      The Medical Review Officer (MRO) assesses a positive result in the light of the donor’s medical background to determine if there is a legitimate medical reason for the result. The MRO helps protect both the rights of the employee being tested and the employer requiring the testing.

      Randox Testing Services

      At Randox Testing Services we offer customers access to our expertise through providing various reporting options to customers. These reporting services can be utilised in cases where extra clarity or examination is needed to investigate the outcome of a drugs test. These reports are utilised by workplaces as well as those operating within the medico-legal sector.

      For more information on our training, education and reporting services, visit https://www.randoxtestingservices.com/workplace-drug-and-alcohol-testing/training-education-reporting-and-policy/

      If you would like to find out more about our drug and alcohol testing programs, contact us today to speak to one of our experience business development executives.

      Email: testingservices@randox.com

      Phone: 028 9592 2801

       

       

      Want to know more?

      Contact us or visit our website to read more.


      Request a meeting
      ×
      Make an Enquiry - RX series
      ×
      Make an Enquiry - Reagents
      ×
      Kit Insert Request - Reagents
      • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
      ×
      Kit Insert Request - Reagents
      • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
      ×
      Make an Enquiry - Reagents
      ×
      Make an Enquiry - Quality Control
      ×
      Make an Enquiry - RIQAS
      ×
      Make an Enquiry - RIQAS
      ×
      Make an Enquiry - Quality Control
      ×
      Make an Enquiry
      • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
      ×
      Make an Enquiry - Biochip
      • This field is for validation purposes and should be left unchanged.
      ×
      Make an Enquiry - Molecular
      • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
      • This field is for validation purposes and should be left unchanged.
      ×
      Make an Enquiry - Future Diagnostics
      ×
      Make an Enquiry - RX series (Product)
      ×
      Make an Enquiry - Quality Control
      • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
      ×
      Make an Enquiry - RIQAS
      • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
      ×
      Make an Enquiry - Reagents
      • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
      ×
      Por favor, introduzca sus datos para ver nuestro último seminario
      ×
      Wyślij zapytanie
      • Rejestracja na naszej liście mailowej jest szybka i łatwa. Nie chcemy wysyłać e-maili zawierających spam lub wiadomości, które są automatycznie przekierowywane do kosza. W zawiązku z czym firma Randox deklaruje, że będzie wysyłac tylko informacje na temat nowych produktów,akutalizacji obecnych, trendów rynkowych, wydarzeń branżowych itp. Firma Randox Laboraotries obiecuje, że Państwa dane nie będą nigdzie przekazane, a przechowywanie owych danych będzie się odbywało z zachowaniem największego bezpieczeństwa. Prosimy o przeczytani naszje Polityki Prywatności.
      ×
      Wyślij zapytanie
      • Rejestracja na naszej liście mailowej jest szybka i łatwa. Nie chcemy wysyłać e-maili zawierających spam lub wiadomości, które są automatycznie przekierowywane do kosza. W zawiązku z czym firma Randox deklaruje, że będzie wysyłac tylko informacje na temat nowych produktów,akutalizacji obecnych, trendów rynkowych, wydarzeń branżowych itp. Firma Randox Laboraotries obiecuje, że Państwa dane nie będą nigdzie przekazane, a przechowywanie owych danych będzie się odbywało z zachowaniem największego bezpieczeństwa. Prosimy o przeczytani naszje polityki prywatności.
      ×
      Wyślij zapytanie
      • Rejestracja na naszej liście mailowej jest szybka i łatwa. Nie chcemy wysyłać e-maili zawierających spam lub wiadomości, które są automatycznie przekierowywane do kosza. W zawiązku z czym firma Randox deklaruje, że będzie wysyłac tylko informacje na temat nowych produktów,akutalizacji obecnych, trendów rynkowych, wydarzeń branżowych itp. Firma Randox Laboraotries obiecuje, że Państwa dane nie będą nigdzie przekazane, a przechowywanie owych danych będzie się odbywało z zachowaniem największego bezpieczeństwa. Prosimy o przeczytani naszje polityki prywatności.
      ×
      Wyślij zapytanie
        Rejestracja na naszej liście mailowej jest szybka i łatwa. Nie chcemy wysyłać e-maili zawierających spam lub wiadomości, które są automatycznie przekierowywane do kosza. W zawiązku z czym firma Randox deklaruje, że będzie wysyłac tylko informacje na temat nowych produktów,akutalizacji obecnych, trendów rynkowych, wydarzeń branżowych itp. Firma Randox Laboraotries obiecuje, że Państwa dane nie będą nigdzie przekazane, a przechowywanie owych danych będzie się odbywało z zachowaniem największego bezpieczeństwa. Prosimy o przeczytani naszje polityki prywatności .
      ×
      귀하의 문의 사항 제출
        Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
      ×
      귀하의 문의 사항 제출
      ×
      귀하의 문의 사항 제출
      ×
      귀하의 문의 사항 제출
      ×
      Downloads
      ×
      Contact

      <p>

        Randox Clinical Chemistry Products Join the Randox Laboratories Mailing List * I would like to receive emails with new product releases and updates from Randox Laboratories, market trends, and more. I do not want to receive email marketing from Randox. Signing up to our mailing list is quick and easy. We do not want to send you any spam or junk emails, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promises never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
      </p>

      ×
      Enquire Now - Coronavirus Testing
      • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details safe and secure. Read more in our Privacy Policy.
      ×